Aslay Biogen Private Limited
Pharmaceutical trading company supplying quality products.
2018 | Patna, Bihar (India) | Active
Aslay Biogen Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.10 M
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Ebitda 150.22%
- Net Worth 3.33%
- Total Assets 59.65%
About Aslay Biogen
Aslay Biogen Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 April 2018 (Six years and ten months 16 days old ). Its registered office is in Patna, Bihar, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.10 M, as per Ministry of Corporate Affairs (MCA) records.
Amit Sinha, Shambhu Sharma, and Anuradha serve as directors at the Company.
Company Details
- Location
Patna, Bihar, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999BR2018PTC037819
- Company No.
037819
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Apr 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Pharma
What products or services does Aslay Biogen Private Limited offer?
Aslay Biogen Private Limited offers a wide range of products and services, including Dentist Tools, Equipment & Supplies, Dental Equipment, Dental Instruments, Autoclaves, Sterilizers & Incubators, Laboratory Autoclave & Sterilizers, Boilers & Boiler Parts, Industrial Boilers.
Who are the key members and board of directors at Aslay Biogen?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anuradha  | Managing Director | 12-Apr-2018 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amit Sinha | Director | 28-Jan-2019 | Current |
| Shambhu Sharma | Director | 12-Apr-2018 | Current |
Financial Performance of Aslay Biogen.
Aslay Biogen Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth moved up by a moderate rise of 3.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aslay Biogen?
In 2019, Aslay Biogen had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aslay Biogen?
Unlock and access historical data on people associated with Aslay Biogen, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aslay Biogen, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aslay Biogen's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.